ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Nurix
The Program Manager will build and maintain integrated project plans for early development programs, coordinating across research, translational sciences, safety, CMC, clinical, regulatory, and biometrics functions. They will also run the day‑to‑day rhythm of a partnered governance committee, managing agendas, minutes, action items, and risk tracking to ensure clear decision‑making and program visibility.
Headquarters
Brisbane, California, United States
Company Size
201-500 employees
Founded
2012
Nurix Therapeutics is a clinical-stage biopharmaceutical company developing medicines that harness targeted protein degradation to treat cancer and autoimmune diseases. Using a proprietary platform that combines small-molecule degraders and Degradation Activating Compounds (DACs) to engage E3 ubiquitin ligases and the ubiquitin–proteasome system, Nurix aims to selectively remove disease-causing proteins. The company advances multiple discovery and development programs and collaborates with partners to translate its platform into novel therapies. Their mission, "Medicines to Outmatch Disease," guides efforts to create differentiated, targeted treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Nurix.
Nurix didn’t post a salary, so this is our estimate from similar listings.
Nurix Therapeutics: Why This Company Could Double In Value? (NASDAQ:NRIX)
1 month ago
Director, Early Development - Clinical Sciences
Tarsus Pharmaceuticals
CMC Program Lead
Telix Pharmaceuticals
Associate Director, Program and Alliance Management - Discovery to Phase II
Monte Rosa Therapeutics, Inc
CMC Regulatory Affairs Project Manager - Foster City, CA - Contract
ObjectWin Technology
Senior Director, Program & Portfolio Management
Vera Therapeutics, Inc.
Manager, CMC Program Operations
Intellia Therapeutics
